TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertension

Stopped Due to a delayed start-up and delayed patient inclusion in combination with new available scientific data, continuation of the clinical study no longer serves a scientific purpose.

Conditions

• Albuminuria

Interventions

• DRUG: Dapagliflozin 10Mg Tab
• DRUG: Placebo

Sponsor

University Medical Center Groningen

Collaborators

• [object Object]